<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An immunocompromised patient, 6 weeks after bone marrow transplantation, developed extensive <z:e sem="disease" ids="C0037278" disease_type="Disease or Syndrome" abbrv="">skin infection</z:e> due to Trichophyton rubrum </plain></SENT>
<SENT sid="1" pm="."><plain>Because she could not tolerate <z:chebi fb="0" ids="48339">ketoconazole</z:chebi> and was hypersensitive to <z:chebi fb="0" ids="27779">griseofulvin</z:chebi>, she received <z:chebi fb="0" ids="6076">itraconazole</z:chebi> with complete recovery within 30 days </plain></SENT>
<SENT sid="2" pm="."><plain>This case demonstrates that <z:chebi fb="0" ids="6076">itraconazole</z:chebi> may be effective treatment for <z:e sem="disease" ids="C0011636" disease_type="Disease or Syndrome" abbrv="">dermatophytosis</z:e>, even in immunocompromised hosts, and that there is no cross-reactivity between <z:chebi fb="0" ids="48339">ketoconazole</z:chebi> and <z:chebi fb="0" ids="6076">itraconazole</z:chebi> </plain></SENT>
</text></document>